Literature DB >> 28194882

Is low-molecular-weight heparin beneficial to chronic ulcers? A meta-analysis of randomised control trials.

Chia-Yu Huang1,2, Mun-Yau Choong2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28194882      PMCID: PMC7950054          DOI: 10.1111/iwj.12708

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  4 in total

1.  Skin grafting followed by low-molecular-weight heparin long-term therapy in chronic venous leg ulcers.

Authors:  Raffaele Serra; Gianluca Buffone; Andrea de Franciscis; Diego Mastrangelo; Tiziana Vitagliano; Manfredi Greco; Stefano de Franciscis
Journal:  Ann Vasc Surg       Date:  2011-10-21       Impact factor: 1.466

2.  Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.

Authors:  M Rullan; L Cerdà; G Frontera; L Masmiquel; J Llobera
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

3.  Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Majid Kalani; Jan Apelqvist; Margareta Blombäck; Kerstin Brismar; Björn Eliasson; Jan W Eriksson; Bengt Fagrell; Anders Hamsten; Ole Torffvit; Gun Jörneskog
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

4.  Low molecular weight heparin improves healing of chronic venous ulcers especially in the elderly.

Authors:  Raffaele Serra; Gianluca Buffone; Vincenzo Molinari; Rossella Montemurro; Paolo Perri; Domenico M Stillitano; Bruno Amato; Stefano de Franciscis
Journal:  Int Wound J       Date:  2013-03-21       Impact factor: 3.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.